Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma

Peer Review reports

Original Submission
21 Jul 2008	Submitted	Original manuscript
18 Aug 2008	Reviewed	Reviewer Report - David Gold
21 Aug 2008	Reviewed	Reviewer Report - Stefan Boeck
30 Oct 2008	Author responded	Author comments - Asma Sultana
Resubmission - Version 2
30 Oct 2008	Submitted	Manuscript version 2
20 Dec 2008	Reviewed	Reviewer Report - Stefan Boeck
23 Dec 2008	Reviewed	Reviewer Report - David Gold
16 Feb 2009	Author responded	Author comments - Asma Sultana
Resubmission - Version 3
16 Feb 2009	Submitted	Manuscript version 3
Publishing
25 Feb 2009	Editorially accepted
25 Feb 2009	Article published	10.1186/1471-2407-9-66

Back to article page